BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33544833)

  • 41. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
    Park SH; Ku CR; Moon JH; Kim EH; Kim SH; Lee EJ
    J Clin Endocrinol Metab; 2018 Mar; 103(3):909-916. PubMed ID: 29272449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of long-term remission of acromegaly following surgery.
    Krieger MD; Couldwell WT; Weiss MH
    J Neurosurg; 2003 Apr; 98(4):719-24. PubMed ID: 12691394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Novel Preoperative Score to Predict Long-Term Biochemical Remission in Patients with Growth-Hormone Secreting Pituitary Adenomas.
    Cohen-Cohen S; Rindler R; Botello Hernandez E; Donegan D; Erickson D; Meyer FB; Atkinson JL; Van Gompel JJ
    World Neurosurg; 2024 Feb; 182():e882-e890. PubMed ID: 38123128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transphenoidal pituitary exploration?
    Daud S; Hamrahian AH; Weil RJ; Hamaty M; Prayson RA; Olansky L
    Pituitary; 2011 Dec; 14(4):414-7. PubMed ID: 19904612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
    Falch CM; Dupont AK; Olarescu NC; Wiedmann M; Dahlberg D; Bollerslev J; Berg-Johnsen J; Heck A
    Acta Neurochir (Wien); 2023 Oct; 165(10):3003-3010. PubMed ID: 37665404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluctuation analysis of postoperative secretory status in patients operated for acromegaly.
    Graillon T; Castinetti F; Boucekine M; Cuny T; Morange I; Fuentes S; Figarella-Branger D; Albarel F; Brue T; Dufour H
    Ann Endocrinol (Paris); 2020 Feb; 81(1):11-17. PubMed ID: 31982107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients.
    Guo X; Zhang R; Zhang D; Wang Z; Gao L; Yao Y; Deng K; Bao X; Feng M; Xu Z; Yang Y; Lian W; Wang R; Ma W; Xing B
    J Neurosurg; 2022 Sep; 137(3):618-628. PubMed ID: 35171834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoscopic endonasal transsphenoidal treatment for acromegaly: 2010 consensus criteria for remission and predictors of outcomes.
    Yildirim AE; Sahinoglu M; Divanlioglu D; Alagoz F; Gurcay AG; Daglioglu E; Okay HO; Belen AD
    Turk Neurosurg; 2014; 24(6):906-12. PubMed ID: 25448208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
    Zhang S; Chen J; Yao S; Akter F; Wang Z; Hu B; Zhu D; Duan C; Chen W; Zhu Y; Wang H; Mao Z
    J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of endoscopic versus microscopic transsphenoidal surgery for patients with growth hormone secreting pituitary adenoma: An emulated trial.
    Qiao N; Shen M; He W; He M; Zhang Z; Ye H; Shou X; Wang Y; Zhao Y
    Clin Neurol Neurosurg; 2021 Aug; 207():106781. PubMed ID: 34246994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission.
    Cunha MLVD; Borba LAB; Boguszewski CL
    Endocrine; 2020 Apr; 68(1):182-191. PubMed ID: 32078118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY.
    Anthony JR; Alwahab UA; Kanakiya NK; Pontell DM; Veledar E; Oyesiku NM; Ioachimescu AG
    Endocr Pract; 2015 Sep; 21(9):1001-9. PubMed ID: 26121434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly.
    Bashari WA; Senanayake R; Koulouri O; Gillett D; MacFarlane J; Powlson AS; Fernandez-Pombo A; Bano G; Martin AJ; Scoffings D; Cheow H; Mendichovszky I; Tysome J; Donnelly N; Santarius T; Kolias A; Mannion R; Gurnell M
    Neurosurg Focus; 2020 Jun; 48(6):E8. PubMed ID: 32480379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decades.
    Sala E; Ferrante E; Locatelli M; Rampini P; Mantovani G; Giavoli C; Filopanti M; Verrua E; Malchiodi E; Carrabba G; Arosio M; Beck-Peccoz P; Spada A; Lania AG
    Hormones (Athens); 2014; 13(1):95-103. PubMed ID: 24722132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.
    Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Tamburrano G; Cantore G
    Endocr Relat Cancer; 2003 Dec; 10(4):611-9. PubMed ID: 14713271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.
    Babu H; Ortega A; Nuno M; Dehghan A; Schweitzer A; Bonert HV; Carmichael JD; Cooper O; Melmed S; Mamelak AN
    Neurosurgery; 2017 Aug; 81(2):357-366. PubMed ID: 28368500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.